BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2217688)

  • 1. Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly.
    Ritchie CM; Sheridan B; Fraser R; Hadden DR; Kennedy AL; Riddell J; Atkinson AB
    Q J Med; 1990 Aug; 76(280):855-67. PubMed ID: 2217688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypertension and Cushing's disease].
    Luton JP; Vidal-Trecan G; Mouveroux F; Bricaire H
    Ann Med Interne (Paris); 1983; 134(3):203-8. PubMed ID: 6625411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The renin-angiotensin-aldosterone (RAA) system in endocrine diseases].
    Zdrojewicz Z
    Wiad Lek; 1990 Jul; 43(13):679-84. PubMed ID: 2256331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension in Cushing's syndrome.
    Magiakou MA; Smyrnaki P; Chrousos GP
    Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):467-82. PubMed ID: 16980206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition, blood pressure and the renin-angiotensin system in acromegaly before and after treatment.
    Davies DL; Beastall GH; Connell JM; Fraser R; McCruden D; Teasdale GM
    J Hypertens Suppl; 1985 Dec; 3(3):S413-5. PubMed ID: 2856753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension in Cushing's syndrome: from pathogenesis to treatment.
    Cicala MV; Mantero F
    Neuroendocrinology; 2010; 92 Suppl 1():44-9. PubMed ID: 20829617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of the arterial hypertensive syndrome in Itsenko-Cushing disease].
    Komissarenko IV; Slavnov VN; Cheban AK; Iakovlev AA; Demchenko NP
    Probl Endokrinol (Mosk); 1982; 28(6):28-31. PubMed ID: 6296809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catecholamines, sodium and renin in unilateral renal hypertension in man.
    Weidmann P; Schiffl H; Ziegler WH; Glück Z; Meier A; Keusch G
    Miner Electrolyte Metab; 1982 Feb; 7(2):97-112. PubMed ID: 6763143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenetic aspects of hypertension in Cushing's syndrome.
    Tenschert W; Baumgart P; Greminger P; Vetter W; Vetter H
    Cardiology; 1985; 72 Suppl 1():84-90. PubMed ID: 3902234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of hypertension in obesity.
    Dornfeld LP; Maxwell MH; Waks A; Tuck M
    Kidney Int Suppl; 1987 Oct; 22():S254-8. PubMed ID: 3323617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.
    Saruta T; Suzuki H; Handa M; Igarashi Y; Kondo K; Senba S
    J Clin Endocrinol Metab; 1986 Feb; 62(2):275-9. PubMed ID: 3510223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR; Lopes KL; Carillo BA; Bergamaschi CT; Carmona AK; Casarini DE; Furukawa L; Heimann JC; Campos RR; Dolnikoff MS
    Am J Hypertens; 2007 Jun; 20(6):692-8. PubMed ID: 17531930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markers of vascular function in hypertension due to Cushing's syndrome.
    Zacharieva S; Atanassova I; Nachev E; Orbetzova M; Kirilov G; Kalinov K; Shigarminova R
    Horm Metab Res; 2005 Jan; 37(1):36-9. PubMed ID: 15702437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Age-related changes in the renin-angiotensin-aldosterone system and the sympathetic nervous system in patients with essential hypertension].
    Nami R; Martinelli M; Panza F; Pavese G; Carletti F; Buracchi P; Lucani B; Pazzaglia A; Saia F; Gennari C
    Minerva Cardioangiol; 1993 Sep; 41(9):387-95. PubMed ID: 8259235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.
    Ruano M; Silvestre V; Castro R; García-Lescún MC; Rodríguez A; Marco A; García-Blanch G
    Obes Surg; 2005 May; 15(5):670-6. PubMed ID: 15946459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New data on hormone-dependent hypertension and their significance for the practice].
    Horký K; Petrásek J; Marek J
    Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arterial hypertension in children. II. The pathogenetic mechanisms involved in arterial hypertension and the therapeutic correlates].
    Moraru D
    Pediatrie (Bucur); 1992; 41(3):46-59. PubMed ID: 1327233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis and treatment of endocrine hypertension].
    Saruta T
    Nihon Rinsho; 1989 Sep; 47(9):2013-8. PubMed ID: 2593274
    [No Abstract]   [Full Text] [Related]  

  • 19. [Arterial hypertension in Cushing's disease].
    Zbranca E; Abu Mizar S; Moscovici R
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(2):273-8. PubMed ID: 6545002
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction between serum cholesterol levels and the renin-angiotensin system on the new onset of arterial hypertension in subjects with high-normal blood pressure.
    Borghi C; Veronesi M; Cosentino E; Cicero AF; Kuria F; Dormi A; Ambrosioni E
    J Hypertens; 2007 Oct; 25(10):2051-7. PubMed ID: 17885547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.